Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis

被引:8
|
作者
Milne, George J. [1 ]
Carrivick, Julian [1 ]
Whyatt, David [1 ]
机构
[1] Univ Western Australia, Crawley, WA, Australia
关键词
SARS-CoV-2; COVID-19; Mitigation strategy effectiveness; Modelling; Vaccination; Non-pharmaceutical measures; Revised 2nd January 2022;
D O I
10.1186/s12916-022-02241-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In countries with high COVID-19 vaccination rates the SARS-CoV-2 Delta variant resulted in rapidly increasing case numbers. This study evaluated the use of non-pharmaceutical interventions (NPIs) coupled with alternative vaccination strategies to determine feasible Delta mitigation strategies for Australia. We aimed to understand the potential effectiveness of high vaccine coverage levels together with NPI physical distancing activation and to establish the benefit of adding children and adolescents to the vaccination program. Border closure limited SARS-CoV-2 transmission in Australia; however, slow vaccination uptake resulted in Delta outbreaks in the two largest cities and may continue as international travel increases. Methods An agent-based model was used to evaluate the potential reduction in the COVID-19 health burden resulting from alternative vaccination strategies. We assumed immunity was derived from vaccination with the BNT162b2 Pfizer BioNTech vaccine. Two age-specific vaccination strategies were evaluated, ages 5 and above, and 12 and above, and the health burden determined under alternative vaccine coverages, with/without activation of NPIs. Age-specific infections generated by the model, together with recent UK data, permitted reductions in the health burden to be quantified. Results Cases, hospitalisations and deaths are shown to reduce by (i) increasing coverage to include children aged 5 to 11 years, (ii) activating moderate NPI measures and/or (iii) increasing coverage levels above 80%. At 80% coverage, vaccinating ages 12 and above without NPIs is predicted to result in 1095 additional hospitalisations per million population; adding ages 5 and above reduces this to 996 per million population. Activating moderate NPIs reduces hospitalisations to 611 for ages 12 and over, and 382 per million for ages 5 and above. Alternatively, increasing coverage to 90% for those aged 12 and above is estimated to reduce hospitalisations to 616. Combining all three measures is shown to reduce cases to 158, hospitalisations to 1 and deaths to zero, per million population. Conclusions Delta variant outbreaks may be managed by vaccine coverage rates higher than 80% and activation of moderate NPI measures, preventing healthcare facilities from being overwhelmed. If 90% coverage cannot be achieved, including young children and adolescents in the vaccination program coupled with activation of moderate NPIs appears necessary to suppress future COVID-19 Delta-like transmission and prevent intensive care unit surge capacity from being exceeded.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis
    George J. Milne
    Julian Carrivick
    David Whyatt
    BMC Medicine, 20
  • [2] Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
    Sonabend, Raphael
    Whittles, Lilith K.
    Imai, Natsuko
    Perez-Guzman, Pablo N.
    Knock, Edward S.
    Rawson, Thomas
    Gaythorpe, Katy A. M.
    Djaafara, Bimandra A.
    Hinsley, Wes
    FitzJohn, Richard G.
    Lees, John A.
    Kanapram, Divya Thekke
    Volz, Erik M.
    Ghani, Azra C.
    Ferguson, Neil M.
    Baguelin, Marc
    Cori, Anne
    LANCET, 2021, 398 (10313): : 1825 - 1835
  • [3] A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe
    Altman, George
    Ahuja, Janvi
    Monrad, Joshua Teperowski
    Dhaliwal, Gurpreet
    Rogers-Smith, Charlie
    Leech, Gavin
    Snodin, Benedict
    Sandbrink, Jonas B.
    Finnveden, Lukas
    Norman, Alexander John
    Oehm, Sebastian B.
    Sandkuehler, Julia Fabienne
    Kulveit, Jan
    Flaxman, Seth
    Gal, Yarin
    Mishra, Swapnil
    Bhatt, Samir
    Sharma, Mrinank
    Mindermann, Soren
    Brauner, Jan Markus
    SCIENTIFIC DATA, 2022, 9 (01)
  • [4] A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe
    George Altman
    Janvi Ahuja
    Joshua Teperowski Monrad
    Gurpreet Dhaliwal
    Charlie Rogers-Smith
    Gavin Leech
    Benedict Snodin
    Jonas B. Sandbrink
    Lukas Finnveden
    Alexander John Norman
    Sebastian B. Oehm
    Julia Fabienne Sandkühler
    Jan Kulveit
    Seth Flaxman
    Yarin Gal
    Swapnil Mishra
    Samir Bhatt
    Mrinank Sharma
    Sören Mindermann
    Jan Markus Brauner
    Scientific Data, 9
  • [5] Dataset on SARS-CoV-2 non-pharmaceutical interventions in Brazilian municipalities
    de Souza Santos, Andreza Aruska
    Candido, Darlan da Silva
    de Souza, William Marciel
    Buss, Lewis
    Li, Sabrina L.
    Pereira, Rafael H. M.
    Wu, Chieh-Hsi
    Sabino, Ester C.
    Faria, Nuno R.
    SCIENTIFIC DATA, 2021, 8 (01)
  • [6] Dataset on SARS-CoV-2 non-pharmaceutical interventions in Brazilian municipalities
    Andreza Aruska de Souza Santos
    Darlan da Silva Candido
    William Marciel de Souza
    Lewis Buss
    Sabrina L. Li
    Rafael H. M. Pereira
    Chieh-Hsi Wu
    Ester C. Sabino
    Nuno R. Faria
    Scientific Data, 8
  • [7] Epidemiology Features and Effectiveness of Vaccination and Non-Pharmaceutical Interventions of Delta and Lambda SARS-CoV-2 Variants
    Bai, Wenqing
    Gu, Yue
    Liu, Haoliang
    Zhou, Lei
    CHINA CDC WEEKLY, 2021, 3 (46): : 977 - 982
  • [8] Mitigating the transmission of infection and death due to SARS-CoV-2 through non-pharmaceutical interventions and repurposing drugs
    Mondal, Chittaranjan
    Adak, Debadatta
    Majumder, Abhijit
    Bairagi, Nandadulal
    ISA TRANSACTIONS, 2022, 124 : 236 - 246
  • [9] Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study
    Alicia Rosello
    Rosanna C. Barnard
    David R. M. Smith
    Stephanie Evans
    Fiona Grimm
    Nicholas G. Davies
    Sarah R. Deeny
    Gwenan M. Knight
    W. John Edmunds
    BMC Infectious Diseases, 22
  • [10] Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study
    Rosello, Alicia
    Barnard, Rosanna C.
    Smith, David R. M.
    Evans, Stephanie
    Grimm, Fiona
    Davies, Nicholas G.
    Deeny, Sarah R.
    Knight, Gwenan M.
    Edmunds, W. John
    BMC INFECTIOUS DISEASES, 2022, 22 (01)